Bruce A. Dressman
Eli Lilly (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, Chemical Synthesis and Analysis, Neuroscience and Neuropharmacology Research, Click Chemistry and Applications
Most-Cited Works
- → Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease(1997)619 cited
- → Use of solid supported nucleophiles and electrophiles for the purification of non-peptide small molecule libraries(1996)226 cited
- → Solid phase synthesis of hydantoins using a carbamate linker and a novel cyclization / cleavage step(1996)209 cited
- → Rapid purification of small molecule libraries by ion exchange chromatography(1997)127 cited
- → Azetidinones as vasopressin V1a antagonists(2006)73 cited
- → Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor(2019)56 cited
- → Solid phase synthesis of urea libraries using a diversifiable thiophenoxy carbonyl linker(1998)42 cited
- → Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease(1995)42 cited
- → New dipeptide isosteres useful for the inhibition of HIV-1 protease(1994)32 cited
- → Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity(2016)29 cited